Literature DB >> 18947279

Osteoprotegerin in gingival crevicular fluid under long-term continuous orthodontic force application.

Hilal Uslu Toygar1, Beyza Hancioglu Kircelli, Sule Bulut, Nurzen Sezgin, Bahar Tasdelen.   

Abstract

OBJECTIVE: To investigate the level of osteoprotegerin (OPG) in gingival crevicular fluid (GCF) during tooth movement.
MATERIALS AND METHODS: Twelve patients (13-17 years of age) requiring canine distalization participated in the study. GCF sampling was done at baseline, 1 hour, 24 hours, 168 hours, 1 month, and 3 months from the distal sites of the test and with control teeth after the application of mechanical stress. OPG concentration was detected by enzyme-linked immunosorbent assay.
RESULTS: OPG concentrations in distal sites of the test teeth were decreased in a time-dependent manner. Decreasing is significant when compared with the baseline measurements (P = .038). Variability was detected in the levels of OPG concentration in the distal sites of the control tooth throughout the experimental period.
CONCLUSION: OPG is one of the key mediators responsible for alveolar bone remodeling during tooth movement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18947279     DOI: 10.2319/100507-483.1

Source DB:  PubMed          Journal:  Angle Orthod        ISSN: 0003-3219            Impact factor:   2.079


  11 in total

1.  Force-induced decline of FOXM1 in human periodontal ligament cells contributes to osteoclast differentiation.

Authors:  Qian Li; Jianyun Zhang; Dawei Liu; Yunan Liu; Yanheng Zhou
Journal:  Angle Orthod       Date:  2019-03-28       Impact factor: 2.079

2.  Effects of submucosally administered platelet-rich plasma on the rate of tooth movement.

Authors:  Saraa L Angel; Vilas D Samrit; Om Prakash Kharbanda; Ritu Duggal; Vikas Kumar; Shyam S Chauhan; Poonam Coshic
Journal:  Angle Orthod       Date:  2022-01-01       Impact factor: 2.079

3.  Effects of low-level laser therapy on orthodontics: rate of tooth movement, pain, and release of RANKL and OPG in GCF.

Authors:  Arantza Domínguez; Clara Gómez; Juan Carlos Palma
Journal:  Lasers Med Sci       Date:  2013-12-18       Impact factor: 3.161

4.  Pentraxin-3 levels in gingival crevicular fluid during orthodontic tooth movement in young and adult patients.

Authors:  Petra Surlin; Anne Marie Rauten; Isabela Silosi; Liliana Foia
Journal:  Angle Orthod       Date:  2012-01-03       Impact factor: 2.079

5.  Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement.

Authors:  German Barbieri; Patricia Solano; Jose Antonio Alarcón; Rolando Vernal; Judith Rios-Lugo; Mariano Sanz; Conchita Martín
Journal:  Angle Orthod       Date:  2012-06-18       Impact factor: 2.079

6.  Estimation of alkaline phosphatase in the gingival crevicular fluid during orthodontic tooth movement in premolar extraction cases to predict therapeutic progression.

Authors:  Yamini Jeyraj; Anil Kumar Katta; Venkataramana Vannala; Divya Lokanathan; S N Reddy; K Rajasigamani
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec

Review 7.  Effect of orthodontic forces on cytokine and receptor levels in gingival crevicular fluid: a systematic review.

Authors:  Priyanka Kapoor; Om Prakash Kharbanda; Nitika Monga; Ragini Miglani; Sunil Kapila
Journal:  Prog Orthod       Date:  2014-12-09       Impact factor: 2.750

8.  Comparative evaluation of pentraxin 3 levels in GCF during canine retraction with active tieback and NiTi coil spring: An in vivo study.

Authors:  Pratik Patel; Ravi Shanthraj; A Bhagyalakshmi; Nekta Garg; Anisha Vallakati
Journal:  J Orthod Sci       Date:  2016 Apr-Jun

9.  Expression and Presence of OPG and RANKL mRNA and Protein in Human Periodontal Ligament with Orthodontic Force.

Authors:  Liliana Otero; Dabeiba Adriana García; Liseth Wilches-Buitrago
Journal:  Gene Regul Syst Bio       Date:  2016-01-25

10.  Clinical research: low-level laser therapy in accelerating orthodontic tooth movement.

Authors:  Junyi Zheng; Kai Yang
Journal:  BMC Oral Health       Date:  2021-06-28       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.